Redfund Capital Corporation (CSE:LOAN) (OTC:PNNRF) (“Redfund” or the “Company”) is pleased to share that our client Wildflower Brands products were chosen for the 2019 Oscars Four Seasons Hollywood Swag Bag.
Wildflower Brands Inc. (CSE: SUN) (OTC: WLDFF ) was founded in Vancouver, Canada in 2012. Their products incorporate the synergistic effects of plants and their extracts and are manufactured in the USA in GMP facilities and are third-party lab tested for quality assurance and accurate labeling. Wildflower was selected to provide gifts for the nominees, presenters and talent staying at the luxury Four Seasons Hotel Los Angeles for the 2019 Oscars. The talent will receive their Hollywood Swag Bag luxuries in the comfort of their hotel rooms pre-show. The swag bag this year includes an assortment of Wildflower CBD products, and both hemp-based CBD products contain less than .03% THC. The unique Cool Stick offers quick and convenient relief from muscle, joint, and back pain and the CBD Healing Stick is formulated with therapeutic essential oils like arnica and wintergreen, to help combat acute and stubborn pains and inflammations. (www.buywildflower.com)
Redfund Capital’s incubator program includes marketing initiatives plus exposure of our clients’ brands to help footprint them globally. The Company is fortunate to partner with Karen Lee, the founder of Kaleidoscope Health and Ripped Femme, who has over 10 years experience in formulating and creating nutritional products. She made it possible for the Wildflower products to be featured in a talent give-away products bag for the 2019 Oscars. (www.rippedfemme.com)
“It is exciting to see Canadian companies such as popular Wildflower featured on the worldwide stage as CBD products become mainstream in the retail US marketplace. I want to thank Karen for this marketing opportunity and look forward to her continued support with Redfund’s accelerator and incubator programs. Exposure for our clients’ branded products is key to their successes,” said Meris Kott, CEO of Redfund Capital Corp.
About Redfund Capital
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
For further information please visit www.redfundcapital.com For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 Or email@example.com Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.